Application 018709

Type: NDA
Sponsor: APOTHECON

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	CAPOZIDE 25/15	CAPTOPRIL; HYDROCHLOROTHIAZIDE	TABLET;ORAL	25MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	Yes	No
002	CAPOZIDE 25/25	CAPTOPRIL; HYDROCHLOROTHIAZIDE	TABLET;ORAL	25MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	Yes	No
003	CAPOZIDE 50/25	CAPTOPRIL; HYDROCHLOROTHIAZIDE	TABLET;ORAL	50MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	Yes	No
004	CAPOZIDE 50/15	CAPTOPRIL; HYDROCHLOROTHIAZIDE	TABLET;ORAL	50MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	Yes	No

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	RLD / RS	Approval date
N018709-001	CAPOZIDE 25/15	CAPTOPRIL; HYDROCHLOROTHIAZIDE	25MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12
N018709-002	CAPOZIDE 25/25	CAPTOPRIL; HYDROCHLOROTHIAZIDE	25MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12
N018709-003	CAPOZIDE 50/25	CAPTOPRIL; HYDROCHLOROTHIAZIDE	50MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12
N018709-004	CAPOZIDE 50/15	CAPTOPRIL; HYDROCHLOROTHIAZIDE	50MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 4 of 5 · 176 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N018709-001	CAPOZIDE 25/15	25MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`6a51e52b5d6a…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N018709-002	CAPOZIDE 25/25	25MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`6a51e52b5d6a…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N018709-003	CAPOZIDE 50/25	50MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`6a51e52b5d6a…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N018709-004	CAPOZIDE 50/15	50MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N018709-001	CAPOZIDE 25/15	25MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`1c564ffb4f44…`
2024-02-18 07:12 UTC	2024-02	N018709-002	CAPOZIDE 25/25	25MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`1c564ffb4f44…`
2024-02-18 07:12 UTC	2024-02	N018709-003	CAPOZIDE 50/25	50MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`1c564ffb4f44…`
2024-02-18 07:12 UTC	2024-02	N018709-004	CAPOZIDE 50/15	50MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N018709-001	CAPOZIDE 25/15	25MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`ea1830bbd6c7…`
2023-12-20 04:57 UTC	2023-12	N018709-002	CAPOZIDE 25/25	25MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`ea1830bbd6c7…`
2023-12-20 04:57 UTC	2023-12	N018709-003	CAPOZIDE 50/25	50MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`ea1830bbd6c7…`
2023-12-20 04:57 UTC	2023-12	N018709-004	CAPOZIDE 50/15	50MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N018709-001	CAPOZIDE 25/15	25MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`a72a2bbeb626…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N018709-002	CAPOZIDE 25/25	25MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`a72a2bbeb626…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N018709-003	CAPOZIDE 50/25	50MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`a72a2bbeb626…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N018709-004	CAPOZIDE 50/15	50MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N018709-001	CAPOZIDE 25/15	25MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`9b2671bbb829…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N018709-002	CAPOZIDE 25/25	25MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`9b2671bbb829…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N018709-003	CAPOZIDE 50/25	50MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`9b2671bbb829…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N018709-004	CAPOZIDE 50/15	50MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N018709-001	CAPOZIDE 25/15	25MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`a67488948f0b…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N018709-002	CAPOZIDE 25/25	25MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`a67488948f0b…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N018709-003	CAPOZIDE 50/25	50MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`a67488948f0b…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N018709-004	CAPOZIDE 50/15	50MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N018709-001	CAPOZIDE 25/15	25MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`3f0d92c62455…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N018709-002	CAPOZIDE 25/25	25MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`3f0d92c62455…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N018709-003	CAPOZIDE 50/25	50MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`3f0d92c62455…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N018709-004	CAPOZIDE 50/15	50MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N018709-001	CAPOZIDE 25/15	25MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`053a50430f4f…`
2023-05-13 08:27 UTC	2023-05	N018709-002	CAPOZIDE 25/25	25MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`053a50430f4f…`
2023-05-13 08:27 UTC	2023-05	N018709-003	CAPOZIDE 50/25	50MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`053a50430f4f…`
2023-05-13 08:27 UTC	2023-05	N018709-004	CAPOZIDE 50/15	50MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N018709-001	CAPOZIDE 25/15	25MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`3bdfa0b2c4d7…`
2023-01-26 05:58 UTC	2023-01	N018709-002	CAPOZIDE 25/25	25MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`3bdfa0b2c4d7…`
2023-01-26 05:58 UTC	2023-01	N018709-003	CAPOZIDE 50/25	50MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`3bdfa0b2c4d7…`
2023-01-26 05:58 UTC	2023-01	N018709-004	CAPOZIDE 50/15	50MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N018709-001	CAPOZIDE 25/15	25MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`3a93d1ddd44b…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N018709-002	CAPOZIDE 25/25	25MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`3a93d1ddd44b…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N018709-003	CAPOZIDE 50/25	50MG;25MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`3a93d1ddd44b…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N018709-004	CAPOZIDE 50/15	50MG;15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL	RLD	1984-10-12	`3a93d1ddd44b…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Documents#

Document, Submission type, Date table
Document	Submission type	Date
1044	SUPPL	2009-03-03
1043	SUPPL	2006-05-21